Galectin-1 is inversely associated with type 2 diabetes independently of obesity – A SCAPIS pilot study()

OBJECTIVES: Galectin-1 is a recently discovered adipokine that increases with obesity and increased energy intake in adipose tissue. Our aim was to assess whether serum galectin-1 is associated with type 2 diabetes (T2D) and other parameters of the metabolic syndrome independently of body mass index...

Descripción completa

Detalles Bibliográficos
Autores principales: Fryk, Emanuel, Strindberg, Lena, Lundqvist, Annika, Sandstedt, Mikael, Bergfeldt, Lennart, Mattsson Hultén, Lillemor, Bergström, Göran, Jansson, Per-Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424824/
https://www.ncbi.nlm.nih.gov/pubmed/32812946
http://dx.doi.org/10.1016/j.metop.2019.100017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424824/
https://www.ncbi.nlm.nih.gov/pubmed/32812946
http://dx.doi.org/10.1016/j.metop.2019.100017

Ejemplares similares